The total number of records retrieved from this search are 36. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
IDOV_1149	Virus nameHerpes simplex virus	Virus strainNV1020	Virus genome typeDNA	Virus familyHerpesviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineColon carcinoma cell line	Cell lineSW480	Concentration of cell line2.0E+4 cells per well	In-vitro toxicityNA	AssayWST-1 assay	In-vitro virus concentration1 × 10⁶ pfu/ml	In-vitro result70% cell killing	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID17117895
IDOV_2154	Virus nameEnterovirus	Virus strainEnterovirus B species echovirus 12	Virus genome typeRNA	Virus familyPicornaviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineColon cancer cell line	Cell lineSW480	Concentration of cell lineNA	In-vitro toxicityNA	AssayMicroscopy examination	In-vitro virus concentration1 MOI	In-vitro resultComplete cell death after 2 days	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus can cause induction in apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21999585
IDOV_2155	Virus nameEnterovirus	Virus strainEnterovirus B species echovirus 15	Virus genome typeRNA	Virus familyPicornaviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineColon cancer cell line	Cell lineSW480	Concentration of cell lineNA	In-vitro toxicityNA	AssayMicroscopy examination	In-vitro virus concentration1 MOI	In-vitro resultPartial cell death after 7 days	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus can cause induction in apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21999585
IDOV_2156	Virus nameEnterovirus	Virus strainEnterovirus B species echovirus 17	Virus genome typeRNA	Virus familyPicornaviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineColon cancer cell line	Cell lineSW480	Concentration of cell lineNA	In-vitro toxicityNA	AssayMicroscopy examination	In-vitro virus concentration1 MOI	In-vitro resultComplete cell death after 6 days	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus can cause induction in apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21999585
IDOV_2157	Virus nameEnterovirus	Virus strainEnterovirus B species echovirus 26	Virus genome typeRNA	Virus familyPicornaviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineColon cancer cell line	Cell lineSW480	Concentration of cell lineNA	In-vitro toxicityNA	AssayMicroscopy examination	In-vitro virus concentration1 MOI	In-vitro resultPartial cell death after 7 days	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus can cause induction in apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21999585
IDOV_2158	Virus nameEnterovirus	Virus strainEnterovirus B species echovirus 29	Virus genome typeRNA	Virus familyPicornaviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineColon cancer cell line	Cell lineSW480	Concentration of cell lineNA	In-vitro toxicityNA	AssayMicroscopy examination	In-vitro virus concentration1 MOI	In-vitro resultComplete cell death after 5 days	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus can cause induction in apoptosis	Immunogenic effectNA	Clinical trialNA	PMID21999585
IDOV_2850	Virus nameMeasles virus	Virus strainAttenuated strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineLaboratory grown own culture	Origin of cell lineHuman colorectal cancer cell line	Cell lineSW480	Concentration of cell line1 million cells per well	In-vitro toxicityNA	AssayCell death detection kit	In-vitro virus concentration1 MOI	In-vitro result40% cells survived	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedActivation of caspase-3	Immunogenic effectNA	Clinical trialNA	PMID23586034
IDOV_3570	Virus nameAdenovirus	Virus strainAdenovirus CD55-TRAIL	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationVirus expressingTRAIL gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman colorectal cancer cell line	Cell lineSW480	Concentration of cell line5000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration5 MOI	In-vitro result98% cell viability after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus in combination with induce apiptosis in cancer cell	Immunogenic effectNA	Clinical trialNA	PMID29039580
IDOV_3571	Virus nameAdenovirus	Virus strainAdenovirus CD55-TRAIL	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationVirus expressingTRAIL gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman colorectal cancer cell line	Cell lineSW480	Concentration of cell line5000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration5 MOI	In-vitro result80% cell viability after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus in combination with induce apiptosis in cancer cell	Immunogenic effectNA	Clinical trialNA	PMID29039580
IDOV_3572	Virus nameAdenovirus	Virus strainAdenovirus CD55-TRAIL	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationVirus expressingTRAIL gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman colorectal cancer cell line	Cell lineSW480	Concentration of cell line5000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration5 MOI	In-vitro result70% cell viability after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus in combination with induce apiptosis in cancer cell	Immunogenic effectNA	Clinical trialNA	PMID29039580
IDOV_3573	Virus nameAdenovirus	Virus strainAdenovirus CD55-TRAIL	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationVirus expressingTRAIL gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman colorectal cancer cell line	Cell lineSW480	Concentration of cell line5000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration5 MOI	In-vitro result70% cell viability after 96 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus in combination with induce apiptosis in cancer cell	Immunogenic effectNA	Clinical trialNA	PMID29039580
IDOV_3574	Virus nameAdenovirus	Virus strainAdenovirus CD55-TRAIL	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationVirus expressingTRAIL gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman colorectal cancer cell line	Cell lineSW480	Concentration of cell line5000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result98% cell viability after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus in combination with induce apiptosis in cancer cell	Immunogenic effectNA	Clinical trialNA	PMID29039580
IDOV_3575	Virus nameAdenovirus	Virus strainAdenovirus CD55-TRAIL	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationVirus expressingTRAIL gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman colorectal cancer cell line	Cell lineSW480	Concentration of cell line5000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result70% cell viability after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus in combination with induce apiptosis in cancer cell	Immunogenic effectNA	Clinical trialNA	PMID29039580
IDOV_3576	Virus nameAdenovirus	Virus strainAdenovirus CD55-TRAIL	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationVirus expressingTRAIL gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman colorectal cancer cell line	Cell lineSW480	Concentration of cell line5000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result60% cell viability after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus in combination with induce apiptosis in cancer cell	Immunogenic effectNA	Clinical trialNA	PMID29039580
IDOV_3577	Virus nameAdenovirus	Virus strainAdenovirus CD55-TRAIL	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationVirus expressingTRAIL gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman colorectal cancer cell line	Cell lineSW480	Concentration of cell line5000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result55% cell viability after 96 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus in combination with induce apiptosis in cancer cell	Immunogenic effectNA	Clinical trialNA	PMID29039580
IDOV_3578	Virus nameAdenovirus	Virus strainAdenovirus CD55-TRAIL	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationVirus expressingTRAIL gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman colorectal cancer cell line	Cell lineSW480	Concentration of cell line5000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration15 MOI	In-vitro result95% cell viability after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus in combination with induce apiptosis in cancer cell	Immunogenic effectNA	Clinical trialNA	PMID29039580
IDOV_3579	Virus nameAdenovirus	Virus strainAdenovirus CD55-TRAIL	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationVirus expressingTRAIL gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman colorectal cancer cell line	Cell lineSW480	Concentration of cell line5000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration15 MOI	In-vitro result60% cell viability after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus in combination with induce apiptosis in cancer cell	Immunogenic effectNA	Clinical trialNA	PMID29039580
IDOV_3580	Virus nameAdenovirus	Virus strainAdenovirus CD55-TRAIL	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationVirus expressingTRAIL gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman colorectal cancer cell line	Cell lineSW480	Concentration of cell line5000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration15 MOI	In-vitro result50% cell viability after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus in combination with induce apiptosis in cancer cell	Immunogenic effectNA	Clinical trialNA	PMID29039580
IDOV_3581	Virus nameAdenovirus	Virus strainAdenovirus CD55-TRAIL	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationVirus expressingTRAIL gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman colorectal cancer cell line	Cell lineSW480	Concentration of cell line5000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration15 MOI	In-vitro result40% cell viability after 96 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus in combination with induce apiptosis in cancer cell	Immunogenic effectNA	Clinical trialNA	PMID29039580
IDOV_3582	Virus nameAdenovirus	Virus strainAdenovirus CD55-TRAIL	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationVirus expressingTRAIL gene	Virus aloneNo	Virus in combination with drug/radiationVirus in combination with luteolin (25 micromolar)	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman colorectal cancer cell line	Cell lineSW480	Concentration of cell line5000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration5 MOI	In-vitro result70% cell viability after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus in combination with induce apiptosis in cancer cell	Immunogenic effectNA	Clinical trialNA	PMID29039580
IDOV_3583	Virus nameAdenovirus	Virus strainAdenovirus CD55-TRAIL	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationVirus expressingTRAIL gene	Virus aloneNo	Virus in combination with drug/radiationVirus in combination with luteolin (25 micromolar)	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman colorectal cancer cell line	Cell lineSW480	Concentration of cell line5000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration5 MOI	In-vitro result50% cell viability after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus in combination with induce apiptosis in cancer cell	Immunogenic effectNA	Clinical trialNA	PMID29039580
IDOV_3584	Virus nameAdenovirus	Virus strainAdenovirus CD55-TRAIL	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationVirus expressingTRAIL gene	Virus aloneNo	Virus in combination with drug/radiationVirus in combination with luteolin (25 micromolar)	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman colorectal cancer cell line	Cell lineSW480	Concentration of cell line5000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration5 MOI	In-vitro result20% cell viability after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus in combination with induce apiptosis in cancer cell	Immunogenic effectNA	Clinical trialNA	PMID29039580
IDOV_3585	Virus nameAdenovirus	Virus strainAdenovirus CD55-TRAIL	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationVirus expressingTRAIL gene	Virus aloneNo	Virus in combination with drug/radiationVirus in combination with luteolin (25 micromolar)	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman colorectal cancer cell line	Cell lineSW480	Concentration of cell line5000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration5 MOI	In-vitro result20% cell viability after 96 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus in combination with induce apiptosis in cancer cell	Immunogenic effectNA	Clinical trialNA	PMID29039580
IDOV_3586	Virus nameAdenovirus	Virus strainAdenovirus CD55-TRAIL	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationVirus expressingTRAIL gene	Virus aloneNo	Virus in combination with drug/radiationVirus in combination with luteolin (25 micromolar)	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman colorectal cancer cell line	Cell lineSW480	Concentration of cell line5000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result70% cell viability after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus in combination with induce apiptosis in cancer cell	Immunogenic effectNA	Clinical trialNA	PMID29039580
IDOV_3587	Virus nameAdenovirus	Virus strainAdenovirus CD55-TRAIL	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationVirus expressingTRAIL gene	Virus aloneNo	Virus in combination with drug/radiationVirus in combination with luteolin (25 micromolar)	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman colorectal cancer cell line	Cell lineSW480	Concentration of cell line5000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result40% cell viability after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus in combination with induce apiptosis in cancer cell	Immunogenic effectNA	Clinical trialNA	PMID29039580
IDOV_3588	Virus nameAdenovirus	Virus strainAdenovirus CD55-TRAIL	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationVirus expressingTRAIL gene	Virus aloneNo	Virus in combination with drug/radiationVirus in combination with luteolin (25 micromolar)	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman colorectal cancer cell line	Cell lineSW480	Concentration of cell line5000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result10% cell viability after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus in combination with induce apiptosis in cancer cell	Immunogenic effectNA	Clinical trialNA	PMID29039580
IDOV_3589	Virus nameAdenovirus	Virus strainAdenovirus CD55-TRAIL	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationVirus expressingTRAIL gene	Virus aloneNo	Virus in combination with drug/radiationVirus in combination with luteolin (25 micromolar)	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman colorectal cancer cell line	Cell lineSW480	Concentration of cell line5000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result10% cell viability after 96 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus in combination with induce apiptosis in cancer cell	Immunogenic effectNA	Clinical trialNA	PMID29039580
IDOV_3590	Virus nameAdenovirus	Virus strainAdenovirus CD55-TRAIL	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationVirus expressingTRAIL gene	Virus aloneNo	Virus in combination with drug/radiationVirus in combination with luteolin (25 micromolar)	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman colorectal cancer cell line	Cell lineSW480	Concentration of cell line5000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration15 MOI	In-vitro result60% cell viability after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus in combination with induce apiptosis in cancer cell	Immunogenic effectNA	Clinical trialNA	PMID29039580
IDOV_3591	Virus nameAdenovirus	Virus strainAdenovirus CD55-TRAIL	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationVirus expressingTRAIL gene	Virus aloneNo	Virus in combination with drug/radiationVirus in combination with luteolin (25 micromolar)	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman colorectal cancer cell line	Cell lineSW480	Concentration of cell line5000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration15 MOI	In-vitro result40% cell viability after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus in combination with induce apiptosis in cancer cell	Immunogenic effectNA	Clinical trialNA	PMID29039580
IDOV_3592	Virus nameAdenovirus	Virus strainAdenovirus CD55-TRAIL	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationVirus expressingTRAIL gene	Virus aloneNo	Virus in combination with drug/radiationVirus in combination with luteolin (25 micromolar)	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman colorectal cancer cell line	Cell lineSW480	Concentration of cell line5000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration15 MOI	In-vitro result10% cell viability after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus in combination with induce apiptosis in cancer cell	Immunogenic effectNA	Clinical trialNA	PMID29039580
IDOV_3593	Virus nameAdenovirus	Virus strainAdenovirus CD55-TRAIL	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationVirus expressingTRAIL gene	Virus aloneNo	Virus in combination with drug/radiationVirus in combination with luteolin (25 micromolar)	Immune gene insertion in viral genomeNo	Source of cell lineShanghai cell collection	Origin of cell lineHuman colorectal cancer cell line	Cell lineSW480	Concentration of cell line5000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration15 MOI	In-vitro result8% cell viability after 96 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus in combination with induce apiptosis in cancer cell	Immunogenic effectNA	Clinical trialNA	PMID29039580
IDOV_4300	Virus nameAlphavirus	Virus strainM1	Virus genome typeRNA	Virus familyTogaviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman colorectal adenocarcinoma	Cell lineSW480	Concentration of cell line4000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 pfu	In-vitro result53.8 % cell viability after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis	Immunogenic effectNA	Clinical trialNA	PMID26373347
IDOV_5156	Virus nameAdenovirus	Virus strainAd-ZD55-miR143	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationInsertion of miR143 in adenovirus via homologus recombination	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineChinese academy of science	Origin of cell lineHuman colorectal cancer cell line	Cell lineSW480	Concentration of cell lineNA	In-vitro toxicityNA	AssayCrystal violet staining	In-vitro virus concentration0.01 MOI	In-vitro result100% cell viability	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis as measured by TUNEL assay	Immunogenic effectNA	Clinical trialNA	PMID27725862
IDOV_5157	Virus nameAdenovirus	Virus strainAd-ZD55-miR143	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationInsertion of miR143 in adenovirus via homologus recombination	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineChinese academy of science	Origin of cell lineHuman colorectal cancer cell line	Cell lineSW480	Concentration of cell lineNA	In-vitro toxicityNA	AssayCrystal violet staining	In-vitro virus concentration0.5 MOI	In-vitro result50% cell viability	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis as measured by TUNEL assay	Immunogenic effectNA	Clinical trialNA	PMID27725862
IDOV_5158	Virus nameAdenovirus	Virus strainAd-ZD55-miR143	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationInsertion of miR143 in adenovirus via homologus recombination	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineChinese academy of science	Origin of cell lineHuman colorectal cancer cell line	Cell lineSW480	Concentration of cell lineNA	In-vitro toxicityNA	AssayCrystal violet staining	In-vitro virus concentration1 MOI	In-vitro result30% cell viability	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis as measured by TUNEL assay	Immunogenic effectNA	Clinical trialNA	PMID27725862
IDOV_5159	Virus nameAdenovirus	Virus strainAd-ZD55-miR143	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationInsertion of miR143 in adenovirus via homologus recombination	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineChinese academy of science	Origin of cell lineHuman colorectal cancer cell line	Cell lineSW480	Concentration of cell lineNA	In-vitro toxicityNA	AssayCrystal violet staining	In-vitro virus concentration10 MOI	In-vitro result100% cell killing	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induced apoptosis as measured by TUNEL assay	Immunogenic effectNA	Clinical trialNA	PMID27725862